16 CARCINOGENESIS.pptx

DaminiSingh68 259 views 57 slides Jun 18, 2023
Slide 1
Slide 1 of 57
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57

About This Presentation

Cancer


Slide Content

CARCINOGENESIS Surg Capt Ritu Mehta

Carcinogenesis P rocess by which a normal cell is transformed into a malignant cell

Molecular hallmark of cancer Self sufficiency in growth signals Insensitivity to inhibitory signals Altered cellular metabolism Evasion of apoptosis Sustained angiogenesis Ability to evade and metastasize Ability to evade host immune response

Proto- oncogenes - Normal cellular genes whose products promote cell proliferation Oncogene Mutated or overexpressed version of proto-oncogene Function autonomously No dependence on normal growth promoting signals Oncoproteins Proteins encoded by oncogenes

Types Chemical Carcinogenesis (a) Direct acting carcinogens (b) Indirect acting carcinogens Radiational Carcinogenesis (a) UV Rays (b) Ionizing Radiation Microbial Carcinogenesis (a) Viral (c) Fungal (b) Bacterial (d) Parasitic

Chemical Carcinogenesis

Types of chemical carcinogenesis Initiators P romotors

Chemical Carcinogenesis

Initiator Initiation- results from exposure of cells to a sufficient dose of carcinogenic agent It becomes altered cells which is potentially capable of giving rise to a tumor Not sufficient for tumor formation Causes permanent DNA damage

Promotor Promotor should act after initiator Don't affect DNA and are reversible Tumor don’t occur when promoting agents are applied before initiating agents

INITIATOR CARCINOGEN 1. Induction of Mutation 2. Single dose 3 . Sudden response 4 . Irreversible 5. Acts first 6 . Effective alone 7 . Direct and indirect carcinogens PROMOTOR CARCINOGEN 1. Non Mutagenic 2. Repeated dose 3 . Gradual response 4 . May be reversible 5 . Acts afterwards 6 . Not effective alone 7 . P horbol esters, P henol, P henobarbitone , Hormones, Misc.

Types of initiator Direct acting agents - require no metabolic conversion to become carcinogenic Indirecting acting ag ents- chemicals that require the metabolic conversion to ultimate carcinogen before they become active

Direct Initiators

Indirect Initiators

Polycyclic Aromatic Hydrocarbons Present in fossil fuels Present in smoked meats and fish- produced during broiling and grilling meats Benzo [alpha] pyrene – formed during high temperature combustion of tobacco in cigarettes and causes Lung Cancer Aromatic Amines and Azo Dyes Used in Aniline dye and rubber industries

What does carcinogens do? Causes mutation through out genome Damage to oncogenes and tumor suppressor genes Carcinogens interact with particular DNA sequences

The commonly mutated oncogenes and tumor suppressor are RAS and p53

FACTORS AFFECTING CHEMICAL CARCINOGENESIS Two most important ones are Metabolism of carcinogens Molecular targets of carcinogens

METABOLISM Most indirect carcinogens metabolised by cyt P-450 dependent monooxygenases .

Molecular Targets Because of their chemical structure some carcinogens cause mutations in particular DNA sequence K/A Hotspots e.g. Aflatoxin B1 related HCC shows specific mutation in p53 gene while non aflatoxin HCC shows no mutation of p53.

OCCUPATIONAL CANCERS Agent and its typical use 1.) Arsenic - alloys 2.) Asbestos- floor tile underlaying 3.) Benzene - paint, printing 4.) Cadmium - batteries 5.) Nickel - batteries 6.) Chromium - paint, pigments 7.) PVC - adhesive for plastic Human Cancers caused by it Lung & skin CA Lung, esophageal, gastric, colon CA &Mesothelioma AML Prostate CA Lung CA Lung CA Hepatic angiosarcoma

Radiation carcinogenesis It is in the form of UV rays of sunlight or as ionizing electromagnetic and particulate radiation is mutagenic

Radiational Carcinogenesis Ultraviolet Rays Ionising Radiation

Marie Curie and Irene ?

UV Radiation

Factors determining the Risk of cancer Type of UV rays exposure UV-C:- Highest risk but screened by Ozone UV-B:- Causes cutaneous cancers The intensity of exposure Non Melanomatous skin cancers –Risk is * to total cumulative exposure to UV rad i.e. lifetime sun exposure Melanomas- Intense excessive exposure as in sun bathing Quantity of Melanin in skin Fair skinned /Dark skinned Inherited disorders of NER mechanism Xeroderma Pigmentosum

UV Radiation induced Cancers 1. Squamous Cell Ca 2. Basal cell CA 3. Malignant Melanoma

Mechanism of Carcinogenesis

Formation of pyrimidine molecules Chemical reaction leading to cross linking of pyrimidine bases Distortion of DNA helix Distorted DNA repair Repeated sun exposure causes activation of error prone non templated DNA repair mechanism- mutations in the cell

Ionizing Radiation Electromagnetic Radiation (a) X Rays (b) Gamma Rays (c) Radiofrequency radiation Particulate Radiation (a) Alpha Particles (b) Beta Particles (c) Protons (d) Neutrons

Sources of Ionising Radiation NATURAL Cosmic Rays - sun Terrestrial Radiation - Uranium, Thorium, Radon Inhalation - Radon gas, Thoron gas Ingestion - Red meat, Carrot, White Potato, Banana, Brazil Nuts ARTIFICIAL Medical - X Rays, Nuclear Medicine, CT Scans Industrial - Smoke detectors, Nuclear and Density Gauges Nuclear sources - Nuclear power plants, Yellow cake

Order of Occurrence of Radiation induced cancers Most frequent Leukemia Thyroid cancers Intermediate frequency Ca Breast Ca Lung Salivary gland Tumors Least frequent Skin cancers Bone tumors GIT cancers

Microbial Carcinogenesis

Microbial Carcinogenesis 1. Viral RNA Viruses ( i ) Human T Cell Lymphotropic Virus-1 (ii) HCV DNA Viruses ( i ) HPV (ii) EBV (iii) HBV (iv) Merkel Cell Polyoma Virus (v) Kaposi Sarcoma Virus (HHV-8)

2. Bacterial H . pylori 2. Parasitic Schistosoma haematobium 3. Fungal Aspergillus flavus

Viral Oncogenesis

Human T Cell Lymphotropic Virus-1 Ss RNA Retrovirus Only retrovirus causing human cancers In 3%-5% of infected individuals- Adult T Cell Leukemia/Lymphoma ( ATLL ) 15-20 Million remain infected world wide Endemic in : Japan, Caribbean, South America & Africa Sporadic elsewhere Long latency of 40-60 years after infection Has CD4+ tropism

HTLV-1 Routes of Transmission (Transfer of T cells) Sexual route Blood Products Breast Feeding Mechanism for oncogenesis HTLV-1 genome has- gag, pol, env , tax, HBZ genes Tax- Essential for viral replication HBZ- Alters the transcription of host genes

HEPATITIS C VIRUS SS RNA virus Leads to cell mediated immune reactions Hepatocellular injury HCC

Human Papilloma Virus DNA Virus Atleast 70 Types described Low risk HPVs: 1,2,4,6,7 & 11 (a) Benign squamous papillomas (Warts) High Risk HPVs : 16, 18, 31 & 33 (a) Ca Cervix (b) SCC anogenital region (c) Head and neck cancers ( tonsillar mucosa) Sexually Transmitted

HPV Carcinogenesis

HPV Carcinogenesis

EBV Burkitt Lymphoma (African Form) B cell Lymphomas in Immuno suppressed (HIV/Post organ Transplant immunosuppresssion ) Hodgkin’s Lymphoma Nasopharyngeal Ca Gastric Carcinoma T cell Lymphoma NK Cell Lymphoma

Oncogenesis by EBV Surface glycoproteins of EBV attach to CD21 Oncogenesis is by 3 genes- LMP-1, EBNA-2, vIL-10 LMP-1:- An oncogene acting like CD40 Activates BCL-2 , preventing apoptosis EBNA-2: Activates Cyclin -D vIL-10:- Suppresses activation of T-Cells

Burkitt Lymphoma B Cell Lymphoma Endemic form Central Africa, New Guinea ( Most common childhood tumor) > 90% A frican tumors carry EBV genome 100% patients have elevated antibody titres against EBV capsid Ags Serum Ab titres are correlated with risk of tumor Sporadic form 15-20 % only show EBV genome The Exact mechanism involved is unknown t (8;14)

EBV positive B Cell Lymphomas in Immunosuppressed Immunosuppressed HIV Post organ/BM transplant immunosuppression Arises at multiple sites: Gut, CNS etc Consistently Express- LMP1 & EBNA 2 Lack MYC translocations

Nasopharyngeal Carcinoma Endemic form Southern China Parts of Africa 100% of NPCs contain EBV genome Abs against EBV elevated Ig A antibodies appear before the tumor in endemic areas Express LMP-1, EBNA 2 & PDL-1

Hepatitis B Virus 70%-85% HCCs are attributable to HBV & HCV infections Exact Mode of oncogenesis not fully known But seems to be immunologically mediated .

Chronic viral infection Plethora of GF, Cytokines, Chemokines Compensatory proliferation of hepatocytes & Release of ROS- genotoxic and mutagenic HCC HBX gene of HBV activates transcription factors

Merkel cell Polyomavirus Merkel Cell Carcinoma (Skin cancer) Kaposi Sarcoma Virus (HHV 8) - Kaposi Sarcoma Primary effusion lymphoma Multicentric Castleman’s disease - lymphoproliferative disorder.

Helicobacter Pylori First Bacteria classified as a carcinogen Implicated in Gastric Adenocarcinoma Gastric Lymphoma ( MALToma ) Gastric Ca occurs in 3% of infected individuals

Oncogenesis mechanism same as HBV- Chronic inflammation increased epithelial cell proliferation ROS Mutagenic Cag A gene - penetrates gastric epithelial cells

H Pylori: Gastric Lymphoma B cell Origin Location- Stomach They resemble the Payer’s patches origin: MALToma H Pylori reactive T-Cell mediated stimulation of B Cells Initially Curable But later not amenable Later becomes T cell independent Lymphoma

PARASITIC Schistoma haematobium -SCC of urinary bladder

FUNGAL Aspergillus flavus - Grows in stored grains - Liberates Aflatoxin - Causes HCC

THANK YOU
Tags